The Delhi Irrigation and Flood Control Department (I&FCD) has informed the National Green Tribunal (NGT) that work on desilting all its drains will be completed by June 15. With more than 20 lakh ...

ISLAMABAD: After a gap of more than six months, the Higher Education Commission (HEC) finally has a chairman, as Prof Dr Niaz Ahmad Akhtar (Sitara-i-Imtiaz) assumed office on Friday with what he ...

TJC LP (“TJC” or “the Firm”), a middle-market private equity firm investing primarily in North America, today announced that the Firm earned the #4 ranking on the HEC Paris-Dow Jones 2025 Global ...

Francisco Partners Ranks in Top Three of the HEC Paris-Dow Jones Annual Global Large Buyout Performance Ranking for Sixth Consecutive Year #2 ranking reflects consistent strong performance over the ...

ISLAMABAD: Vice Chancellor Quaid-i-Azam University Prof Dr Niaz Ahmad Akhtar is likely to be new Chairman Higher Education Commission (HEC). Reliable sources said that name of Dr Niaz has almost been ...

Pakistan has launched the Maktab system to keep full digital records of students, tracking their enrolment, grades, transcripts, and degrees, Minister of State for Federal Education Wajiha Qamar said ...

From the first Android TV unit I bought in 2015 to the Chromecast with Google TV and now the Google TV Streamer, nearly every streaming box I’ve used with an Android-based operating system has ...

A former Newark police officer has filed a federal lawsuit alleging years of sexual harassment — including advances from Mayor Ras Baraka — and retaliation after testing positive for prescribed ...

If the AquaNor conference in Trondheim feels busier this year, we might have land-based aquaculture to thank. Investment in the industry exceeded $1.3 billion during the first half of 2025 and could ...

Home equity contracts promise no payments but demand high end-term paybacks. Federal regulators warn HECs mirror risky loans from the 2008 housing crash. Rising home values and opaque terms raise long ...

Revolution Medicines has secured a potential funding infusion of up to $2 billion from Royalty Pharma in return for a slice of the profits if Revolution’s lead cancer drug makes it to market.